Search research articles
Contact Us
Filters
Showing results (81-90 of 154) with videos related to
Page
of 16
Sort By:
CNS Drugs
|
October 24, 2013
Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications
George Anderson, Michael Berk, Olivia Dean, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
July 2, 2017
Affective symptoms in schizophrenia are strongly associated with neurocognitive deficits indicating disorders in executive functions, visual memory, attention and social cognition
Buranee Kanchanatawan, Supaksorn Thika, George Anderson, et al.
Nanotechnology
|
January 13, 2017
The prospects of phosphorene as an anode material for high-performance lithium-ion batteries: a fundamental study
Congyan Zhang, Ming Yu, George Anderson, et al.
Current Pharmaceutical Design
|
December 16, 2015
The Many Neuroprogressive Actions of Tryptophan Catabolites (TRYCATs) that may be Associated with the Pathophysiology of Neuro-Immune Disorders
Gerwyn Morris, André F Carvalho, George Anderson, et al.
Health Promotion Journal of Australia : Official Journal of Australian Association of Health Promotion Professionals
|
September 10, 2014
Twitter tweets and twaddle: twittering at AHPA. National Health Promotion Conference
George Anderson, Suzanne Gleeson, Chris Rissel, et al.
Current Pharmaceutical Design
|
September 9, 2016
Gut Permeability and Microbiota in Parkinson's Disease: Role of Depression, Tryptophan Catabolites, Oxidative and Nitrosative Stress and Melatonergic Pathways
George Anderson, Moonsang Seo, Michael Berk, et al.
CNS Spectrums
|
August 27, 2015
Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways
Marta Martin-Subero, George Anderson, Buranee Kanchanatawan, et al.
Clinical Spine Surgery
|
July 24, 2023
Spinal Cord Stimulators and Intrathecal Pain Pump Removal Versus Retention During Posterior Lumbar Fusion: A Matched Cohort Analysis
Christopher L McDonald, Daniel Alsoof, George Anderson, et al.
Pharmacological Reports : PR
|
February 21, 2014
Increased IL-6 trans-signaling in depression: focus on the tryptophan catabolite pathway, melatonin and neuroprogression
George Anderson, Marta Kubera, Weronika Duda, et al.
Heart (British Cardiac Society)
|
March 10, 2018
Phosphodiesterase-5 inhibitors and the heart: compound cardioprotection?
David Charles Hutchings, Simon George Anderson, Jessica L Caldwell, et al.
Page
of 16
Search research articles
Search
Showing results (81-90 of 154) with videos related to
Sort By:
Page
of 16
CNS Drugs
|
October 24, 2013
Role of immune-inflammatory and oxidative and nitrosative stress pathways in the etiology of depression: therapeutic implications
George Anderson, Michael Berk, Olivia Dean, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
July 2, 2017
Affective symptoms in schizophrenia are strongly associated with neurocognitive deficits indicating disorders in executive functions, visual memory, attention and social cognition
Buranee Kanchanatawan, Supaksorn Thika, George Anderson, et al.
Nanotechnology
|
January 13, 2017
The prospects of phosphorene as an anode material for high-performance lithium-ion batteries: a fundamental study
Congyan Zhang, Ming Yu, George Anderson, et al.
Current Pharmaceutical Design
|
December 16, 2015
The Many Neuroprogressive Actions of Tryptophan Catabolites (TRYCATs) that may be Associated with the Pathophysiology of Neuro-Immune Disorders
Gerwyn Morris, André F Carvalho, George Anderson, et al.
Health Promotion Journal of Australia : Official Journal of Australian Association of Health Promotion Professionals
|
September 10, 2014
Twitter tweets and twaddle: twittering at AHPA. National Health Promotion Conference
George Anderson, Suzanne Gleeson, Chris Rissel, et al.
Current Pharmaceutical Design
|
September 9, 2016
Gut Permeability and Microbiota in Parkinson's Disease: Role of Depression, Tryptophan Catabolites, Oxidative and Nitrosative Stress and Melatonergic Pathways
George Anderson, Moonsang Seo, Michael Berk, et al.
CNS Spectrums
|
August 27, 2015
Comorbidity between depression and inflammatory bowel disease explained by immune-inflammatory, oxidative, and nitrosative stress; tryptophan catabolite; and gut-brain pathways
Marta Martin-Subero, George Anderson, Buranee Kanchanatawan, et al.
Clinical Spine Surgery
|
July 24, 2023
Spinal Cord Stimulators and Intrathecal Pain Pump Removal Versus Retention During Posterior Lumbar Fusion: A Matched Cohort Analysis
Christopher L McDonald, Daniel Alsoof, George Anderson, et al.
Pharmacological Reports : PR
|
February 21, 2014
Increased IL-6 trans-signaling in depression: focus on the tryptophan catabolite pathway, melatonin and neuroprogression
George Anderson, Marta Kubera, Weronika Duda, et al.
Heart (British Cardiac Society)
|
March 10, 2018
Phosphodiesterase-5 inhibitors and the heart: compound cardioprotection?
David Charles Hutchings, Simon George Anderson, Jessica L Caldwell, et al.
Page
of 16